Top Markets
#1 Siren Siren +34.29%
#2 Wiki Cat Wiki Cat +29.28%
#3 Bitway Bitway +20.25%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.79%
#5 TRIA TRIA +17.08%
#6 PulseChain PulseChain +16.92%
#7 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.84%
#8 Velvet Velvet +15.27%
#9 Cysic Cysic +14.22%
#10 The Grays Currency The Grays Currency +14.20%
Coin of the day
Siren Siren
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Pozycja w akcjach #30681
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Cena akcji
$0.91968646
Kapitalizacja rynkowa
$15.91M
Zmiana (1 dzień)
2.23%
Zmiana (1 rok)
-54.41%
Kraj
KR
Handel Xcell Therapeutics, Inc. (373110)

Kategoria

Healthcare
Historia ceny akcji dla Xcell Therapeutics, Inc. (373110)
Najwyższa cena zamknięcia: $0.93 dnia 2026-08-01

Najniższa cena zamknięcia: $5.30 dnia 2024-07-01
Historia cen akcji firmy Xcell Therapeutics, Inc. od 2024 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 5.84%
2025 -59.67%
2024 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 50.70%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.31 -36.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.87%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 13.01%
BE